SDF-1 expression and tumor-infiltrating lymphocytes identify clinical subtypes of triple-negative breast cancer with different responses to neoadjuvant chemotherapy and survival
BackgroundIn this study, we investigated the prediction and prognostic value of SDF-1 for triple-negative breast cancer (TNBC) patients who underwent neoadjuvant chemotherapy (NAC) following standard V-Neck radical surgery.MethodsA total of 303 TNBC patients were included in this study.The NAC regimen was weekly paclitaxel plus carboplatin (PC) for